Condition: Biomarkers · Lung Adenocarcinoma · Pleural Effusion · Sponsor: Fu Jen Catholic University
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
This description comes directly from the study's public registry record.
Ke-Yun Chao, PhD · +886905301879 · ck_qq@hotmail.com
Always discuss trial participation with your own doctor first.
| Fu Jen Catholic University Hospital, Fu Jen Catholic University | New Taipei City, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07012759